These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 2036817)

  • 1. A comparative study of efficacy and safety of arformoterol and salbutamol nebulization as rescue therapy in acute non-severe asthma.
    Das SK; Biswas I; Bandyopadhyay AK; Bairagya TD; Bhattacharya S
    Indian J Pharmacol; 2011 Jul; 43(4):463-5. PubMed ID: 21845007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indacaterol, A Novel Once Daily Inhaled beta2-Adrenoreceptor Agonist.
    Roig J; Hernando R; Mora R
    Open Respir Med J; 2009 Mar; 3():27-30. PubMed ID: 19452036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and bronchodilator effects of inhaled rac-formoterol in subjects with chronic obstructive pulmonary disease: a dose-response study.
    Whale CI; Sovani MP; Mortimer KJ; Harrison TW; Tattersfield AE
    Br J Clin Pharmacol; 2008 Jun; 65(6):841-7. PubMed ID: 18394012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypokalaemia in healthy volunteers after single and multiple doses of formoterol or salbutamol.
    van den Berg BT; Louwerse RT; Luiken GJ; Jonkers RE; van Boxtel CJ
    Clin Drug Investig; 1998; 15(6):523-9. PubMed ID: 18370510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised, double-blind, placebo-controlled study to evaluate the role of formoterol in the management of acute asthma.
    Najafizadeh K; Sohrab Pour H; Ghadyanee M; Shiehmorteza M; Jamali M; Majdzadeh S
    Emerg Med J; 2007 May; 24(5):317-21. PubMed ID: 17452695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease.
    Cazzola M; Matera MG; Donner CF
    Drugs; 2005; 65(12):1595-610. PubMed ID: 16060696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled short acting beta agonist use in COPD and the risk of acute myocardial infarction.
    Suissa S; Assimes T; Ernst P
    Thorax; 2003 Jan; 58(1):43-6. PubMed ID: 12511719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects.
    Guhan AR; Cooper S; Oborne J; Lewis S; Bennett J; Tattersfield AE
    Thorax; 2000 Aug; 55(8):650-6. PubMed ID: 10899240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma.
    Bartow RA; Brogden RN
    Drugs; 1998 Feb; 55(2):303-22. PubMed ID: 9506248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unsuspected coronary artery disease revealed by administration of nebulised salbutamol.
    Montgomery HE; Gill J; Pumphrey CW
    Br Heart J; 1994 Aug; 72(2):181. PubMed ID: 7917693
    [No Abstract]   [Full Text] [Related]  

  • 11. Long- versus short-acting beta 2-agonists. Implications for drug therapy.
    Boulet LP
    Drugs; 1994 Feb; 47(2):207-22. PubMed ID: 7512898
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety of formoterol Turbuhaler at cumulative dose of 90 microg in patients with acute bronchial obstruction.
    Malolepszy J; Böszörményi Nagy G; Selroos O; Larsso P; Brander R
    Eur Respir J; 2001 Dec; 18(6):928-34. PubMed ID: 11829098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta 2-agonists administered by a dry powder inhaler can be used in acute asthma.
    Nana A; Youngchaiyud P; Maranetra N; Boe J; Löfdahl CG; Selroos O; Ståhl E
    Respir Med; 1998 Feb; 92(2):167-72. PubMed ID: 9616507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
    Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
    Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formoterol as a rescue medication for asthma.
    Antoniu SA
    Expert Opin Pharmacother; 2006 Dec; 7(17):2439-41. PubMed ID: 17109618
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of maximal doses of formoterol and salbutamol from a metered dose inhaler on pulse rates, ECG, and serum potassium concentrations.
    Maesen FP; Costongs R; Smeets JJ; Brombacher PJ; Zweers PG
    Chest; 1991 Jun; 99(6):1367-73. PubMed ID: 2036817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease.
    Cazzola M; D'Amato M; Califano C; Di Perna F; Calderaro E; Matera MG; D'Amato G
    Clin Ther; 2002 Apr; 24(4):595-604. PubMed ID: 12017404
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.